Richard Sherman, Swedish donors support new program that combines genomic medicine, supportive care
FOR IMMEDIATE RELEASE
Contacts: Clay Holtzman, Swedish, 206-386-2748, firstname.lastname@example.org
SEATTLE — April 28, 2014
— The Swedish Cancer Institute (SCI) today announced its new Personalized Medicine Program that combines advanced medical treatments based on the unique, molecular signature of a patient’s cancer with supportive care that is designed to serve each individual’s physical and emotional health.
“Patients diagnosed with cancer often find themselves having to choose between advanced treatment programs typically associated with academic or research centers, and the patient-centered care they expect from their community hospital,” said SCI Executive Director Thomas Brown, M.D. “The Swedish Cancer Institute has a long history of extraordinary care, and with the addition of genomic medicine, we are continuing our legacy of giving patients the best of both worlds, now through our Personalized Medicine Program.”
Each patient is unique at the cellular level, so understanding the molecular fingerprint of an individual’s cancer helps guide treatment decisions. Combined with the comprehensive social services available to address the complex needs of patients and their families, SCI is striving to provide the most comprehensive, best-practice approach to treating cancer.
To kick-off the Personalized Medicine Program, SCI is launching a public awareness campaign that includes informative content on SwedishCancerInstitute.org as well as television spots, the first of which features Seattle Seahawks All-Pro Cornerback Richard Sherman. The video is available for viewing here.
“When I was asked to support the Swedish Cancer Institute’s Personalized Medicine Program, I realized I had a new opportunity to continue my passion for supporting the Seattle community,” said Sherman, who was recently named one of the 2014’s 100 Most Influential People in the World by TIME
. “I’m honored to be a part of the innovative work the Swedish Cancer Institute is doing on behalf of patients and families across our region.”